Search Within

Joachim Yahalom

  1. "2021"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (9)
  3. Editorial (1)
  4. Guidelines (1)
  5. Review (1)
Groups
  1. Radiation Oncology, Department of (25)
  2. Survivorship Research (25)
  3. Department of Medicine (15)
  4. Hematologic Malignancies, Division of (14)
  5. Center for Hematologic Malignancies (13)
  6. Graduate Medical Education (13)

More Groups

People
  1. Brandon Imber (12)
  2. Carla Hajj (11)
  3. Maria Palomba (11)
  4. Andrew Zelenetz (8)
  5. Connie Batlevi (8)
  6. Neil Wijetunga (8)

More People

Years
  1. 2021 (25)
Publications
  1. Blood (8)
  2. International Journal of Radiation Oncology, Biology, Physics (6)
  3. Blood Advances (2)
  4. British Journal of Radiology (2)
  5. Hematological Oncology (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Elsevier Inc. (6)
  3. American Society of Clinical Oncology (2)
  4. British Institute of Radiology (2)
  5. Wiley Blackwell (2)
  6. Nature Publishing Group (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • "Big Boom" radiation treatment (RT) of 4 Gy single fraction: Is it an acceptable alternative to "Boom Boom" radiation treatment 2 Gyx2 fractions for non-Hodgkin lymphomas (NHL)?
    Meeting Abstract

    Hajj, C.; Lee, J.; Fregonese, B.; Imber, B. S.; Wijetunga, N. A.; Yang, J. C.; Casey, D. L.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Efficacy and toxicity of alternative radiation treatment schemes for patients with hematologic malignancies: A collaborative ILROG COVID era report
    Meeting Abstract

    Gunther, J. R.; Yang, J. C.; Hajj, C.; Ng, A. K.; Brady, J. L.; Cheng, S.; Levis, M.; Qi, S.; Mikhaeel, G.; Ricardi, U.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Lymphoma: Advances in imaging and radiotherapy – Introductory editorial
    Editorial

    Illidge, T.; Mikhaeel, N. G.; Specht, L.; Yahalom, J.
    British Journal of Radiology (2021)

    Fulltext@MSK | Save
  • A picture is worth a thousand words: A history of diagnostic imaging for lymphoma
    Review

    Wijetunga, N. A.; Imber, B. S.; Caravelli, J. F.; Mikhaeel, N. G.; Yahalom, J.
    British Journal of Radiology (2021)

    Fulltext@MSK | Save
  • Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: Is 4 Gy suitable for curable patients?
    Journal Article

    Imber, B. S.; Chau, K. W.; Lee, J.; Lee, J.; Casey, D. L.; Yang, J. C.; Wijentunga, N. A.; Shepherd, A.; Hajj, C.; Qi, S.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy
    Journal Article

    Chelius, M.; Chau, K.; Yang, J.; Hajj, C.; Imber, B.; Yahalom, J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT
    Journal Article

    Lopez-Alonso, R.; Qi, S.; Mashiach, T.; Weiler-Sagie, M.; Yahalom, J.; Dann, E. J.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save